梁宏课题组
导师介绍
当前位置: 首页  导师介绍
​陈振锋 博士;教授;博士生导师



Tel: +86-773-2120998

Fax: +86-773-2120958

E-mail: chenzf@gxnu.edu.cn

基本介绍

广西师范大学-省部共建药用资源化学与药物分子工程国家重点实验室常务副主任,教授,博士生导师,省级重点学科无机化学和广西高校百名中青年学科带头人之一,教育部创新团队负责人,教育部新世纪优秀人才支持计划人选,广西首批八桂学者,国家有突出贡献的中青年专家,国家人社部"百千万人才工程"入选者,广西科学技术特别贡献奖获得者,第二批广西院士后备人选。《广西师范大学学报》编委和《Crystal & Growth Design》,《CrystEngComm,Dalton Trans.》,《Evidence Based Complementary and Alternative Medicine》,《Mini-Reviews in Medicinal Chemistry》,《Eur. J. Med. Chem.》,《Bioorg. & Med. Chem. Lett.》,《Inorganic Chemistry Communications》,《Inorg. Chim. Acta,Appl. Organometal. Chem.》,《J. Coord. Chem.》,《中国科学》,《化学学报》,《结构化学》,《有机化学》等近20种刊物的审稿人。已在《Chem. Eur. J.》,《Chem. Commun.》,《Analytical Chemistry》,《Inorg. Chem.,Organometallics》,《CrystEngComm》,《Dalton Trans.》,《J. Biol. Inorg. Chem.》,《J. Inorg. Biochem.》,《Eur. J. Med. Chem.》,《Bioorg. & Med. Chem. Lett.》,《Anti-Cancer Agents in Medicinal Chemistry》,《Eur. J. Inorg. Chem.》等国际、国内刊物正式发表SCI收录论文120余篇,他人引用1100余次。获第八届“广西青年科技奖”,自治区级教学成果奖三等奖(排名第4),广西科学技术进步奖一等奖(排名第2),以及广西自然科学奖二等奖(排名第4)和三等奖(排名第1)各一项。先后主持973计划前期研究专项1项,国家自然科学基金项目3项,教育部”创新团队发展计划”项目1项,教育部重点项目2项,教育部“新世纪优秀人才支持计划”资助项目1项,广西自然科学基金项目4项。作为第二成员参与国家自然科学基金地区基金联合资助项目1项,973计划前期研究专项各3项。近年来已指导或合作硕士研究生40多名,独立或合作指导博士研究生8名。

教育背景

1998.09-2001.06 南京大学,化学化工学院,博士

1995.09-1998.06 广西师范大学,化学化工学院,硕士

1989.09-1993.06 广西师范学院,化学系,学士

工作经历

2018.03-2018.06 广西社会主义学院党外中青年干部培训班学习,任组长

2017.12-今 九三学社第十一次全国代表大会代表

2016.05-今 中国科协九大全国代表大会代表

2016.01-今 广西师范大学-省部共建药用资源化学与药物分子工程国家重点实验室常务副主任

2010.08-2015.12 国家重点实验室培育基地常务副主任

2006.01-2015.12 广西师范大学,教育部重点实验室常务副主任,化学化工学院副院长,中华青年联合会第十届委员会委员(2006-2010)

2005.01-今 广西师范大学,广西重点实验室常务副主任

2004.03-2006.03 广西师范大学,化学化工学院,分工会主席

2003.12-2004.12 广西师范大学,广西高校重点实验室主任

2001.07-2003.11 广西师范大学化学与药学学院,无机化学教研室主任

荣誉及奖励

1)广西科学技术特别贡献奖(2017

2)国家重点实验室固定研究人员(2016

3)享受国务院政府特殊津贴人员(2016

4)广西自然科学奖二等奖(2016

5)国家人社部"百千万人才工程"入选者(2015

6)国家有突出贡献的中青年专家(2015

7)广西自然科学奖三等奖(2012

8)教育部创新团队负责人(2012

9)广西首批八桂学者(2011

10)第八届“广西青年科技奖”(2006

11)自治区级教学成果奖三等奖(2005

12)教育部新世纪优秀人才支持计划人选(2004

10)广西科技进步奖一等奖(2003

11)广西高校百名中青年学科带头人之一(2002

12)广西师范大学优秀青年教师(2001

Representative Publications

1. Zhen-FengChen,* Qi-Pin Qin, Jiao-Lan Qin, Yan-Cheng Liu, Ke-Bin Huang, Yu-Lan Li,Ting Meng, Guo-Hai Zhang,Yan Peng, Xu-Jian Luo, Hong Liang*. Stabilization of G-quadruplex DNA, inhibition of telomerase activity, and tumor cell apoptosis by organoplatinum(II) complexes with oxoisoaporphine. J. Med. Chem., 2015, 58, 21592179.

2. Zhen-Feng Chen,* Qi-Pin Qin, Jiao-Lan Qin, Jie Zhou, Yu-Lan Li, Nan Li, Yan-Cheng Liu, Hong Liang*. Water-soluble ruthenium(II) complexes with chiral 4-(2,3-dihydroxypropyl)-formamide oxoaporphine (FOA): invitro and in vivo anticancer activity by stabilization of G-quadruplex DNA, inhibition of telomerase activity, and induction of tumor cell apoptosis. J. Med. Chem., 2015, 58, 47714789.

3. Ke-Bin Huang, Feng-Yang Wang, Xiao-Ming Tang, Hai-Wen Feng, Zhen-Feng Chen*, Yan-Cheng Liu, You-Nian Liu and Hong Liang*. Organometallic gold(III) complexes similar to tetrahydroisoquinoline (THIQ) induce ER-stress-mediated apoptosis and pro-death autophagy in A549 cancer cells. J. Med. Chem., 2018, 61, 34783490.

4. Qi-Pin Qin, Jiao-Lan Qin, Ting Meng, Wan-Hua Lin, Chuan-Hui Zhang, Zu-Zhuang Wei, Jia-Nian Chen, Yan-Cheng Liu, Hong Liang, Zhen-Feng Chen*. High in vivo antitumor activity of cobalt oxoisoaporphine complexes by targeting G-quadruplex DNA, telomerase and disrupting mitochondrial functions. Eur. J. Med. Chem., 2016, 124, 380−392.

5. Yan-Cheng Liu, Jian-Hua Wei, Zhen-Feng Chen*, Mei Liu, Yun-Qiong Gu, Ke-Bin Huang, Zhu-Quan Li and Hong Liang*. The antitumor activity of zinc(II) and copper(II) complexes with 5,7-dihalo-substituted-8-quinolinoline. Eur. J. Med. Chem., 2013, 69,554563.

6. Guohai Zhang, Yunfeng An, Xing Lu, Hui Zhong, Yanhong Zhu, Yiming Wu, Feng’e, Ma, Jingmei Yang, Yancheng Liu, Zuping Zhou, Yan Peng*, Zhenfeng Chen*. A novel naphthalimide compound restores p53 function in non–small–cell lung cancer by reorganizing the Bak–Bcl-xl complex and triggering transcriptional regulation. J. Biol. Chem., 2016, 291, 42114225.

7. Pei Liu, Jin-ling Liu, Heng-shan Wang,Ying-ming Pan*, Hong Liang, and Zhen-Feng Chen*. Copper-mediated crossing-coupling/cyclization/oxidation: One-pot to construct polysubstituted pyrroles. Chem. Commun. 2014, 50, 47954798.

8. Xu Wang, Shen-yan Li, Ying-ming Pan*, Heng-shan Wang, Hong Liang, Zhen-Feng Chen*, and Xiao-huan Qin. Samarium(III)-catalyzed C(sp3)–H bond activation: Synthesis of indolizines via C–C and C–N coupling between 2-alkylazaarenes and propargylic alcohols. Org. Lett., 2014, 16, 580583.

9. Pei Liu, Heng-shan Wang, Ying-ming Pan,* Wei-long Dai, Hong Liang and Zhen-Feng Chen*. The first palladium-catalyzed 1,4-addition of terminal alkenes to acrylate esters. Chem. Commoun., 2013, 49, 52955297.

10. Qi-Pin Qin, Jiao-Lan Qin, Ming Chen, Yu-Lan Li, Ting Meng, Jie Zhou, Hong Liang*, Zhen-Feng Chen*. Chiral platinum(II)-4-(2,3-Dihydroxypropyl)- formamide oxoaporphine (FOA) complexes promote tumor cells apoptosis by directly targeting G-quadruplex DNA in vitro and in vivo. Oncotarget, 2017, 8, 6198261997.

11. Jiao-Lan Qin, Ting Meng, Zhen-Feng Chen*, Xiao-Li Xie, Qi-Pin Qin, Xiao-Ju He, Ke-Bin Huang, Hong Liang*. Facile total synthesis of lysicamine and the anticancer activities of the RuII, RhIII, MnII and ZnII complexes of lysicamine. Oncotarget, 2017, 8, 5935959375.


点击次数: 70 更新时间: 2021-05-19